Riskpilot← Back to searchSign inGet full accessPlusTerveys Hammasklinikat Oy
OYActiveY-tunnus 3265145-7Malmin Asematie 6Dental practice care activities · NACE 8623Est. 2022— employees
Revenue 2024
EUR 21,5M
+5% vs 2023
EBITDA margin
6.5%
+21% vs 2023
Equity ratio
48.6%
Financial strength
Net profit 2024
EUR 63K
-81% vs 2023
| Revenue | EUR 21,5M | +5% |
| EBITDA | EUR 1,4M | +21% |
| Net profit | EUR 63K | -81% |
| Total assets | EUR 6M | +16% |
| Equity | EUR 2,9M | +2% |
| Employees | — | — |
Legal name
PlusTerveys Hammasklinikat Oy
Y-tunnus number
3265145-7
Legal form
Osakeyhtiö
NACE code
8623 · Dental practice care activities
Founded
28. tammikuuta 2022
Share capital
EUR 10 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on hammaslääkäripalveluiden sekä muiden suun terveydenhuollon palveluiden ja näitä tukevien palveluiden tuottaminen. Yhtiö voi omistaa ja hallita toimitiloja, koneita ja välineitä sekä vuokrata vastaanottojen käyttöoikeuksia ja siihen liittyvän henkilökunnan palveluksia ja harjoittaa henkilövuokrausta. Yhtiö voi harjoittaa terveydenhoitoalan koneiden, välineiden ja tarveaineiden maahantuontia, välitystä ja kauppaa. Yhtiö voi harjoittaa toimintaa suoraan tai yhteistyössä muiden saman toimialan toimijoiden kanssa. Lisäksi yhtiö voi omistaa kiinteää omaisuutta, muiden yhtiöiden ja yhteisöjen osakkeita sekä harjoittaa arvopaperikauppaa ja sijoitustoimintaa.
Address
Malmin Asematie 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 20 574 | 21 509 |
| Staff expenses | −6 822 | −7 338 |
| EBITDA | 1 158 | 1 406 |
| Depreciation & amort. | −735 | −769 |
| EBIT | 423 | 638 |
| Net financials | 14 | 29 |
| Profit before tax | 337 | 67 |
| Tax | 8 | 4 |
| Net profit | 329 | 63 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 5 178 | 5 994 |
| Equity | 2 852 | 2 914 |
| Long-term debt | — | 0 |
| Short-term debt | 231 878 | 3 072 |
| Total debt | — | 0 |
EBITDA margin
6.5%
This company
15.8%
Market median
-59% vs market
20232024
Equity ratio
48.6%
This company
38.2%
Market median
+27% vs market
20232024
Return on equity
2.1%
This company
18.4%
Market median
-89% vs market
20232024
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20232024
Asset turnover
3.59×
This company
1.12×
Market median
+221% vs market
20232024
Debt / equity
1.06×
This company
0.62×
Market median
-71% vs market
20232024
| Name | Role | Member since |
|---|---|---|
| Current (10) | ||
JR Chief Executive Officer | Chief Executive Officer | 2025 |
SP Person with significant control | Person with significant control | 2023 |
PK Person with significant control | Person with significant control | 2026 |
PJ Person with significant control | Person with significant control | 2023 |
ME Person with significant control | Person with significant control | 2023 |
MT Person with significant control | Person with significant control | 2026 |
HC Person with significant control | Person with significant control | 2023 |
CM Person with significant control | Person with significant control | 2023 |
PM Person with significant control | Person with significant control | 2023 |
TT Person with significant control | Person with significant control | 2023 |
| Former (3) | ||
KM Person with significant control | Person with significant control | 2023 – 2025 |
TM Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
RA | Audit | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Former (6) | ||
| Board of Directors | 2023 – 2023 | |
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2023 – 2025 | |
| Board of Directors | 2022 – 2023 | |
| Chairperson | 2022 – 2026 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PlusTerveys Oy | Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PlusTerveys Hammasklinikat Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Joni Raimo Mikael Aaltonen | Chief Executive Officer | 0 companies |
| Seija Päivikki Nurmi | Person with significant control | 0 companies |
| Piia Kaarina Klemetti | Person with significant control | 0 companies |
| Pertti Juhani Patinen | Person with significant control | 0 companies |
| Kirsi Marja Anneli Saares | Person with significant control | 0 companies |
| Mika Eerik Alho | Person with significant control | 0 companies |
| Marko Tapio Savolainen | Person with significant control | 0 companies |
| Tiina Marjaana Ristola | Chief Executive Officer | 0 companies |
| Reeta Alina Virolainen | Audit | 0 companies |
| Heidi Christina Mäkinen | Person with significant control | 0 companies |
| Carola Marianne Valkama | Person with significant control | 0 companies |
| Pia Maria Kittelä | Person with significant control | 0 companies |
| Tero Tapio Tuominen | Person with significant control | 0 companies |
| Petri Juha Lahdentausta | Board of Directors | 0 companies |
| Pentti Ilmari Rytivaara | Board of Directors | 0 companies |
| Sirkku Saila Kaarina Meriläinen | Board of Directors | 0 companies |
| Petri Juhani Hammar | Board of Directors | 0 companies |
| Antti-Jussi Juutinen | Board of Directors | 0 companies |
| Timo Ilmari Kauppila | Board of Directors | 0 companies |
| Kati Maria Niemelä | Board of Directors | 0 companies |
| Henri Markus Kiviaho | Board of Directors | 0 companies |
| Matti Pentti Pöyry | Board of Directors | 0 companies |
| Ossi Mikael Pohjola | Chairperson | 0 companies |